Angiogenesis(血管生成)
- Cat.No. 产品名称 Information
-
GC17263
Leukadherin 1
An allosteric activator of CD11b/CD18
-
GC14857
LFM-A13
A BTK inhibitor
-
GC19222
Lifitegrast
立他司特; SAR 1118; SHP-606
An inhibitor of the LFA-1/ICAM-1 interaction -
GC90787
Lipid A4
一种分支离子化阳离子脂质类物质。
-
GC13227
LRGILS-NH2
LRGILS-NH2 是一种反向序列蛋白酶激活受体-2 (PAR-2)-失活的阴性对照,SLIGRL-NH2 是一种 PAR-2 激活肽。
-
GC47582
Lupulone
蛇床酮
A beta-acid -
GC32724
LW6 (HIF-1α inhibitor)
HIF-1α inhibitor; LW8
LW6是一种缺氧诱导因子1(hypoxia inducing factor 1, HIF)抑制剂,通过降解HIF-1α有效抑制HIF-1α的积累,但不影响缺氧时HIF- 1a mRNA水平。 -
GC36500
LXW7
LXW7 是一种八聚二硫环肽,为整合素 αvβ3 的配体,能够有效、特异性地靶作用于内皮祖细胞 (EPCs) 和内皮细胞 (ECs)。在 ECs 细胞中,LXW7 可增强 VEGFR-2 的磷酸化和 ERK1/2 的活化。
-
GC40865
LYG-202
A synthetic flavonoid with anticancer and anti-angiogenic activities
-
GC32055
MK-0429 (L-000845704)
L-000845704
MK-0429 (L-000845704) (L-000845704) 是一种具有口服活性的、有效的、选择性的非肽类泛整合素拮抗剂,对于 α 的 IC50 值为 1.6 nM、2.8 nM、0.1 nM、0.7 nM、0.5 nM 和 12.2 nM ;vβ1, αvβ3, αvβ5, αvβ6, αvβ8 and α5β1, respectively. -
GC19251
MK-8617
A HIF-PH1, -2, and -3 inhibitor
-
GC14319
ML 228
CID-46742353
A HIF pathway activator -
GC13004
ML161
ML161
Reversible inhibitor of PAR1-mediated platelet activation -
GC18608
MMP-2/MMP-9 Inhibitor II
Matrix Metalloproteinase-2/Matrix Metalloproteinase-9 Inhibitor II
A dual inhibitor of MMP-2 and MMP-9 -
GC18616
MMP-8 Inhibitor I
Matrix Metalloproteinase-8 Inhibitor I
A selective inhibitor of MMP-8 -
GC10048
MNS
3,4-亚甲二氧-beta-硝基苯乙烯,NSC 170724; 5-(2-Nitrovinyl)benzodioxole
An inhibitor of Src, Syk, and platelet aggregation -
GC10046
Molidustat (BAY85-3934)
BAY 85-3934
A pan-HIF-PH inhibitor -
GC36661
MT-802
MT-802 is a potent PROTAC that induces Bruton's tyrosine kinase (BTK) knockdown. MT-802 recruits BTK to the cereblon E3 ubiquitin ligase complex to trigger BTK ubiquitination and degradation via the proteasome. MT-802 has potential for treatment of C481S mutant chronic lymphocytic leukemia (CLL).
-
GC49686
N-desmethyl Regorafenib N-oxide
瑞戈非尼杂质14
An active metabolite of regorafenib -
GC62255
N-piperidine Ibrutinib hydrochloride
N-piperidine Ibrutinib hydrochloride, a reversible Ibrutinib derivative, is a potent BTK inhibitor with IC50s of 51.0 and 30.7 nM for WT BTK and C481S BTK, respectively.
-
GC44290
NAADP (sodium salt)
Nicotinic acid adenine dinucleotide phosphate
A secondary messenger that induces calcium mobilization
-
GC61109
Natalizumab
那他珠单抗
Natalizumab是一种重组的人源化单克隆抗体,与α4β1-整联蛋白(α4β1-integrin)结合并阻断其与血管细胞粘附分子1(VCAM-1)的相互作用。Natalizumab可用于复发缓解型多发性硬化症和克罗恩氏病的研究。Natalizumab也可阻止淋巴细胞进入中枢神经系统,从而防止急性脱髓鞘复发。 -
GC44358
Nebivolol O-β-D-Glucuronide
An active metabolite of nebivolol
-
GC91360
NM-3
NM-3是一种合成异香豆素,可以抑制血管生成。
-
GC73434
NRX-0492
NRX-0492是一种口服有效的BTK降解剂。
-
GC44465
NSC 12
NSC 172285
An FGF inhibitor -
GC44475
NVP-BEZ235 (hydrochloride)
Dactolisib
Dual inhibitor of PI3K and mTOR -
GC69600
NX-2127
NX-2127 是一种口服有效的 BTK 抑制剂,可诱导细胞中突变的 BTKC481S 降解。NX-2127 抑制 BTKC481S 突变体 TMD8 细胞的增殖,比 Ibrutinib 更有效。NX-2127 催化 Ikaros (IKZF1) 和 Aiolos (IKZF3) 的降解,对应的作用浓度分别为 25 nM 和 54 nM。NX-2127 刺激 T 细胞活化并增加原代人 T 细胞中 IL-2 的产生。
-
GC49349
O-Desethyl Sildenafil
西地那非杂质C
A metabolite of sildenafil -
GC16107
Obtustatin
整合素 α1β1 抑制剂
-
GC74342
Obtustatin triacetate
Obtustatin triacetate是一种41个残基的非RGD解整合素。
-
GC17358
Octyl-α-ketoglutarate
α-KG octyl ester
A cell-permeable form of α-ketoglutarate -
GC15199
OGT 2115
An inhibitor of heparanase
-
GC12821
Oltipraz
奥替普拉; RP 35972; NSC 347901
A Nrf2 and CAR activator -
GC13219
ONO-4059
GS-4059 analog
A derivative of ONO-4059 -
GC69630
Orbofiban acetate
Orbofiban acetate是一种口服活性血小板膜糖蛋白IIb/IIIa拮抗剂,抑制血小板聚集。
-
GC41625
Oroxylin A
千层纸素A; Baicalein 6-methyl ether; 6-Methoxybaicalein
A flavonoid with diverse biological activities -
GC36821
OSU-T315
OSU-T315 (ILK-IN-1) is a small Integrin-linked kinase (ILK) inhibitor with an IC50 of 0.6 μM, inhibiting PI3K/AKT signaling by dephosphorylation of AKT-Ser473 and other ILK targets (GSK-3β and myosin light chain).
-
GN10452
Paeoniflorin
芍药苷; Peoniflorin
A monoterpene glycoside with diverse cellular actions -
GC11951
PAR 4 (1-6)
H-甘氨酸-酪氨酸-脯氨酸-甘氨酸-谷氨酸-缬氨酸-OH
A peptide agonist of PAR4 -
GC62101
PAR-2-IN-1
IUN76750 is a PAR-2 signaling pathway inhibitor.
-
GA23350
PAR-3 (1-6) amide (human)
A peptide agonist of PAR1 and PAR2
-
GC15817
PAR-4 Agonist Peptide, amide (AY-NH2)
PAR-4-AP; AY-NH2
PAR-4 Agonist Peptide, amide(AY-NH2) (PAR-4-AP; AY-NH2) 是一种蛋白酶激活的受体 4 (PAR-4) 激动剂,对 PAR-1 或 PAR- 均无影响2 并且其作用被 PAR-4 拮抗剂阻断。 -
GC33599
PAR-4 Agonist Peptide, amide TFA (PAR-4-AP (TFA))
PAR-4-AP TFA; AY-NH2 TFA
PAR-4 Agonist Peptide, amide TFA (PAR-4-AP (TFA)) 是一种合成肽,主要用于激活蛋白酶激活受体4(PAR-4)。 -
GC69663
Parstatin(mouse) TFA
Parstatin(mouse) TFA 是具有细胞通透性的 PAR-1 凝血酶受体的肽类激动剂,是一种有效的血管生成抑制剂。
-
GC40085
Pazopanib-d6
培唑帕尼-d6,GW786034-d6
An internal standard for the quantification of pazopanib -
GC36861
PCI 29732
4-氨基-1-环戊基-3-(4-苯氧基苯基)-1H-吡唑并[3,4-D]嘧啶
A multi-kinase inhibitor -
GC13812
PCI-32765 (Ibrutinib)
伊布替尼; PCI-32765
PCI-32765 (Ibrutinib) 是一种不可逆的选择性布鲁顿氏酪氨酸激酶 (BTK) 抑制剂,可选择性靶向其激酶结构域并通过降低其磷酸化能力来调节 BTK 下游信号传导,在无细胞试验中 IC50 为 0.5 nM 。 -
GC12921
PCI-32765 Racemate
1-[3-[4-氨基-3-(4-苯氧基苯基)-1H-吡唑并[3,4-D]嘧啶-1-基]哌啶-1-基]丙-2-烯-1-酮,PCI-32765 Racemate
PCI-32765 Racemate (PCI-32765 Racemate) 是依鲁替尼的外消旋体。 Ibrutinib 是一种选择性的、不可逆的 Btk 抑制剂,IC50 值为 0.5 nM。 -
GC30155
PCI-33380
PCI-33380是布鲁顿酪氨酸激酶(BTK)的不可逆抑制剂(荧光探针)。